View in your browser
{journal}
15th February 2012 International Drug Reference Issue 22

In this issue
Budenofalk 9mg granules
Sycrest sublingual tablets
Important Safety Information
Important Safety Information
Important Safety Information
Recall

Topics
New Products
Advisories, Manufacturer Updates, etc.
New Products

Budenofalk 9mg granules

Budesonide, corticosteroid

by Carolyn Bugler

Read more »

Sycrest sublingual tablets

Asenapine, atypical antipsychotic

by Carolyn Bugler

Read more »

Advisories, Manufacturer Updates, etc.

Important Safety Information

Correct administration of VELCADE (bortezomib) is via the intravenous route.

by Carolyn Bugler

Read more »

Important Safety Information

by Carolyn Bugler

Strengthening the cardiovascular monitoring during treatment initiation with Gilenya (fingolimod) in patients with Relapsing Remitting Multiple Sclerosis.

Read more »

Recall

Class 2 Drug Alert Accord Healthcare Limited Amoxicillin EL(12)A/02

by Carolyn Bugler

Read more »

Copyright © ICR (UK) Limited.  Contact peter@medicalimi.com.  All rights reserved.

Click here for details of our Data Protection & Privacy Policy 2011

You're receiving this newsletter because you opted to subscribe when signed up for our printed journal.
Not interested in receiving this newsletter anymore? Unsubscribe Instantly. Got a new address? Change your preferences.